Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fructose | 9 | 2021 | 72 | 5.250 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 13 | 2022 | 245 | 2.990 |
Why?
|
| Glucose | 12 | 2023 | 1246 | 2.360 |
Why?
|
| Liver | 11 | 2022 | 2906 | 1.690 |
Why?
|
| Lipogenesis | 10 | 2022 | 77 | 1.310 |
Why?
|
| Transcription Factors | 8 | 2023 | 5259 | 1.280 |
Why?
|
| Insulin | 13 | 2021 | 1447 | 1.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2022 | 1360 | 1.210 |
Why?
|
| Nuclear Proteins | 8 | 2022 | 3319 | 1.180 |
Why?
|
| Insulin Resistance | 10 | 2022 | 730 | 0.970 |
Why?
|
| Triglycerides | 4 | 2022 | 604 | 0.910 |
Why?
|
| Lipase | 2 | 2021 | 113 | 0.900 |
Why?
|
| Succinic Acid | 1 | 2022 | 23 | 0.880 |
Why?
|
| Systems Analysis | 1 | 2021 | 17 | 0.820 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 4 | 2021 | 421 | 0.820 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 84 | 0.790 |
Why?
|
| Fibroblast Growth Factors | 3 | 2017 | 261 | 0.780 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 106 | 0.750 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 131 | 0.720 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 229 | 0.720 |
Why?
|
| Homeostasis | 6 | 2023 | 950 | 0.700 |
Why?
|
| Fructose Intolerance | 2 | 2017 | 4 | 0.680 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 120 | 0.660 |
Why?
|
| Adipose Tissue | 3 | 2014 | 766 | 0.620 |
Why?
|
| Adipocytes | 3 | 2015 | 304 | 0.610 |
Why?
|
| Insulin-Secreting Cells | 4 | 2022 | 154 | 0.600 |
Why?
|
| Intestine, Small | 1 | 2021 | 499 | 0.600 |
Why?
|
| Obesity | 10 | 2022 | 2893 | 0.590 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 2021 | 95 | 0.550 |
Why?
|
| Thermogenesis | 1 | 2015 | 48 | 0.520 |
Why?
|
| Blood Glucose | 7 | 2021 | 1242 | 0.510 |
Why?
|
| Animals | 28 | 2023 | 59540 | 0.490 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 354 | 0.480 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 1439 | 0.480 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 905 | 0.470 |
Why?
|
| Membrane Proteins | 2 | 2021 | 2817 | 0.440 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 2266 | 0.410 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 1083 | 0.400 |
Why?
|
| Mice | 18 | 2023 | 34442 | 0.400 |
Why?
|
| Mice, Knockout | 6 | 2022 | 5680 | 0.350 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 246 | 0.320 |
Why?
|
| Dyslipidemias | 2 | 2022 | 235 | 0.320 |
Why?
|
| Proteins | 1 | 2015 | 1958 | 0.300 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 4028 | 0.280 |
Why?
|
| Energy Metabolism | 3 | 2017 | 994 | 0.270 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 3 | 2022 | 16 | 0.270 |
Why?
|
| Cholesterol, HDL | 3 | 2022 | 342 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 481 | 0.260 |
Why?
|
| Signal Transduction | 4 | 2016 | 11980 | 0.260 |
Why?
|
| Glucose Intolerance | 2 | 2016 | 83 | 0.230 |
Why?
|
| Lipids | 2 | 2023 | 644 | 0.230 |
Why?
|
| Glycolysis | 2 | 2016 | 523 | 0.230 |
Why?
|
| Glucose Transporter Type 4 | 3 | 2014 | 26 | 0.230 |
Why?
|
| Adiposity | 2 | 2018 | 238 | 0.230 |
Why?
|
| Succinates | 1 | 2022 | 20 | 0.220 |
Why?
|
| Humans | 31 | 2023 | 262238 | 0.220 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2022 | 32 | 0.220 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 2 | 2021 | 12 | 0.210 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 86 | 0.210 |
Why?
|
| Weight Loss | 4 | 2022 | 629 | 0.210 |
Why?
|
| Lipoproteins | 2 | 2022 | 252 | 0.210 |
Why?
|
| Hexoses | 1 | 2021 | 11 | 0.200 |
Why?
|
| Keto Acids | 1 | 2021 | 59 | 0.200 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 380 | 0.200 |
Why?
|
| Rodentia | 1 | 2021 | 64 | 0.190 |
Why?
|
| Dietary Sugars | 1 | 2021 | 18 | 0.190 |
Why?
|
| Body Weight | 2 | 2019 | 1291 | 0.190 |
Why?
|
| Carbohydrate Metabolism | 1 | 2021 | 74 | 0.190 |
Why?
|
| Bariatric Surgery | 2 | 2019 | 109 | 0.190 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2020 | 4 | 0.180 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 15 | 0.180 |
Why?
|
| Food Deprivation | 1 | 2020 | 47 | 0.180 |
Why?
|
| Liver Cirrhosis | 2 | 2018 | 943 | 0.180 |
Why?
|
| Glucagon | 1 | 2020 | 196 | 0.180 |
Why?
|
| Lipoproteins, VLDL | 2 | 2018 | 89 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2021 | 4554 | 0.180 |
Why?
|
| Glucosides | 1 | 2020 | 66 | 0.170 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 85 | 0.170 |
Why?
|
| Haplotypes | 1 | 2021 | 858 | 0.170 |
Why?
|
| Hepatocytes | 2 | 2022 | 347 | 0.170 |
Why?
|
| Mice, Inbred Strains | 1 | 2019 | 517 | 0.170 |
Why?
|
| Cholesterol | 2 | 2022 | 657 | 0.160 |
Why?
|
| Carboxypeptidases A | 1 | 2018 | 5 | 0.160 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2018 | 8 | 0.160 |
Why?
|
| Pharmacogenomic Variants | 1 | 2018 | 29 | 0.160 |
Why?
|
| Terminology as Topic | 1 | 2021 | 416 | 0.160 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 5 | 0.160 |
Why?
|
| Machine Learning | 1 | 2021 | 320 | 0.160 |
Why?
|
| Sugars | 1 | 2018 | 15 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 6916 | 0.160 |
Why?
|
| Fatty Liver | 2 | 2017 | 234 | 0.160 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 27 | 0.160 |
Why?
|
| Fasting | 2 | 2017 | 350 | 0.160 |
Why?
|
| Intestines | 1 | 2022 | 688 | 0.160 |
Why?
|
| Sweetening Agents | 1 | 2017 | 33 | 0.150 |
Why?
|
| RNA, Messenger | 2 | 2021 | 6132 | 0.150 |
Why?
|
| Male | 17 | 2022 | 123290 | 0.150 |
Why?
|
| Beverages | 1 | 2017 | 105 | 0.150 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 677 | 0.150 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2016 | 21 | 0.150 |
Why?
|
| Colon | 1 | 2021 | 673 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 800 | 0.140 |
Why?
|
| Eye Proteins | 1 | 2018 | 269 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2021 | 9293 | 0.140 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2016 | 165 | 0.140 |
Why?
|
| Mutation, Missense | 1 | 2021 | 1154 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 250 | 0.140 |
Why?
|
| Gastrectomy | 1 | 2019 | 451 | 0.140 |
Why?
|
| Diet | 2 | 2021 | 1451 | 0.130 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2015 | 7 | 0.130 |
Why?
|
| Esters | 1 | 2014 | 46 | 0.130 |
Why?
|
| Female | 16 | 2022 | 142262 | 0.120 |
Why?
|
| Metformin | 1 | 2018 | 378 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2015 | 835 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2015 | 333 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2017 | 2079 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 5541 | 0.100 |
Why?
|
| Phenotype | 2 | 2021 | 6273 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2014 | 449 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2021 | 6892 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 87 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 192 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2010 | 116 | 0.090 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2010 | 44 | 0.090 |
Why?
|
| Protein Phosphatase 2C | 2 | 2021 | 75 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2015 | 2450 | 0.080 |
Why?
|
| Energy Intake | 1 | 2011 | 518 | 0.080 |
Why?
|
| Genotype | 2 | 2018 | 4108 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1515 | 0.080 |
Why?
|
| Leptin | 1 | 2010 | 295 | 0.080 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 566 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2015 | 5606 | 0.080 |
Why?
|
| Cadaver | 2 | 2018 | 241 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 5158 | 0.070 |
Why?
|
| Carbon | 1 | 2006 | 150 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2018 | 568 | 0.070 |
Why?
|
| Oxygen | 1 | 2010 | 754 | 0.070 |
Why?
|
| Biological Transport | 1 | 2006 | 597 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 3084 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 6065 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 7727 | 0.060 |
Why?
|
| Risk Factors | 2 | 2020 | 17607 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2022 | 12914 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2012 | 2213 | 0.060 |
Why?
|
| Rats | 3 | 2018 | 6109 | 0.060 |
Why?
|
| Natriuretic Peptides | 1 | 2022 | 9 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 1066 | 0.060 |
Why?
|
| Malonyl Coenzyme A | 1 | 2022 | 6 | 0.060 |
Why?
|
| Palmitates | 1 | 2022 | 23 | 0.050 |
Why?
|
| Acetyl Coenzyme A | 1 | 2022 | 23 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2022 | 104 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2022 | 74 | 0.050 |
Why?
|
| RNA Interference | 2 | 2018 | 1411 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 7227 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2022 | 106 | 0.050 |
Why?
|
| Particle Size | 1 | 2022 | 186 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 4333 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 830 | 0.050 |
Why?
|
| Feedback | 1 | 2022 | 206 | 0.050 |
Why?
|
| Mutation | 1 | 2021 | 15195 | 0.050 |
Why?
|
| Middle Aged | 8 | 2021 | 86454 | 0.050 |
Why?
|
| Models, Biological | 1 | 2010 | 3250 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 279 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 573 | 0.050 |
Why?
|
| Adult | 7 | 2022 | 78097 | 0.050 |
Why?
|
| Massachusetts | 1 | 2020 | 106 | 0.050 |
Why?
|
| Lipolysis | 1 | 2020 | 109 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 255 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 211 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 60 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2018 | 32 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 116 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2018 | 164 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 63 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 144 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 290 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 241 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2018 | 274 | 0.040 |
Why?
|
| Gastric Bypass | 1 | 2017 | 81 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2021 | 875 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 398 | 0.040 |
Why?
|
| Keratin-18 | 1 | 2016 | 10 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 14594 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2015 | 78 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2015 | 34 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 191 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 625 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 227 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1949 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2014 | 67 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2018 | 7249 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1505 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 1090 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 1556 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 1180 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 582 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 2598 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 702 | 0.030 |
Why?
|
| Housing, Animal | 1 | 2011 | 37 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 1643 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 156 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 1120 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 311 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 485 | 0.020 |
Why?
|
| Environment | 1 | 2011 | 190 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 622 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 703 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 1085 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 4140 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 2917 | 0.020 |
Why?
|
| Incidence | 1 | 2020 | 5710 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 1298 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 2436 | 0.020 |
Why?
|
| Body Composition | 1 | 2011 | 596 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 5049 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 4321 | 0.020 |
Why?
|
| Registries | 1 | 2016 | 2187 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1067 | 0.020 |
Why?
|
| Metabolome | 1 | 2010 | 343 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 12968 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 4350 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 6695 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 2515 | 0.020 |
Why?
|
| Aged | 2 | 2018 | 70329 | 0.010 |
Why?
|
| United States | 1 | 2016 | 15564 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 29999 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 31261 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 32994 | 0.010 |
Why?
|